Related Experiment Video
Updated: May 9, 2026
07:13
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
South Asians' cardiac medication adherence.
Twyla A Ens1, Cydnee C Seneviratne1, Charlotte Jones2
1Faculty of Nursing, University of Calgary, Canada.
European Journal of Cardiovascular Nursing
|July 16, 2013
Summary
South Asian cardiac patients often struggle with medication adherence due to side effects, cost, and forgetfulness. Understanding these factors is key to improving cardiac health outcomes for this population.
Area of Science:
- Cardiology
- Public Health
- Pharmacology
Background:
- South Asians exhibit disproportionately high rates of cardiovascular disease.
- Suboptimal adherence to cardiac medication regimens is a concern within this demographic compared to Caucasians.
- Identifying adherence factors is crucial for enhancing cardiac health among South Asians.
Purpose of the Study:
- To conduct a narrative review of current knowledge on cardiac medication adherence in South Asian patients.
- To identify barriers and facilitators influencing medication adherence in this population.
Main Methods:
- A comprehensive literature search was performed across multiple databases (CINAHL, Medline, PsychINFO, EMBASE, Cochrane).
- Keywords included 'South Asian', 'cardiac medication adherence', and related terms.
- English language studies published between 1980 and 2013 were included, with abstracts and manuscripts reviewed for eligibility and validity.
Main Results:
- Thirteen studies, primarily from India and Pakistan, formed the final dataset.
- Key non-adherence factors identified include medication side effects, cost, forgetfulness, and frequent dosing schedules.
- Language barriers and limited knowledge about medications were also significant contributors to non-adherence.
Conclusions:
- Non-adherence to cardiac medications among South Asians is a complex issue with multiple contributing factors.
- Further research is needed to explore decision-making processes regarding cardiac medication adherence in South Asian immigrants in Western countries.
Related Concept Videos
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:22Heart Failure Drugs: β-Blockers
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:26Angina IV: Management
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...